GameStop and the “meme” stocks have attracted much of the market’s attention in recent weeks, but cannabis stocks have been the market’s real standout in 2021 thanks to renewed expectations of U.S. legalization.

Cybin has closed on a CAD$34 million bought deal financing. Has raised nearly CAD$90 million to date.

Bills to legalize marijuana in Virginia advanced out of two committees on Wednesday, the final step before full floor action.

Somerville in January became the first jurisdiction in Massachusetts to move toward decriminalizing plant-based psychedelic drugs, with city leaders voting unanimously to recognize the medical uses of natural entheogens — including psilocybin, the active ingredient in “magic mushrooms” — and make them among the lowest enforcement priorities for local police.

THE NASCENT PSYCHEDELIC industry is booming as several companies have gone public and more are expected to follow this route in 2021 to attract more capital from institutional and retail investors.

ATAI Life Sciences is set to become the new industry leader among psychedelic stocks. But it may not be the best OPPORTUNITY for investors when trading begins.

Tryp Therapeutics announces a CAD$2.0 private placement at a unit price of CAD$0.60

A bipartisan group of lawmakers reintroduced a bill in Congress on Thursday that would allow hemp and CBD derived from the crop to be marketed and sold as dietary supplements.

The first modern antidepressants were originally tuberculosis medications, created from leftover World War II rocket fuel.

A Sunday report from Global News spotlights a unique way that some people are coping with the stress and anxiety of the coronavirus pandemic — magic mushrooms. ​​​​​​​